share_log

Crexendo Analyst Ratings

Benzinga Analyst Ratings ·  Sep 27, 2022 08:55
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/27/2022 67.36% Northland Capital Markets → $4 Initiates Coverage On → Outperform
05/13/2022 67.36% B. Riley Securities $6.5 → $4 Maintains Buy
03/22/2022 192.89% Lake Street $9 → $7 Maintains Buy
03/22/2022 171.97% B. Riley Securities $8.25 → $6.5 Maintains Buy
11/22/2021 276.57% Lake Street → $9 Initiates Coverage On → Buy
09/29/2020 234.73% B. Riley Securities → $8 Initiates Coverage On → Buy

Crexendo Questions & Answers

What is the target price for Crexendo (CXDO)?

The latest price target for Crexendo (NASDAQ: CXDO) was reported by Northland Capital Markets on September 27, 2022. The analyst firm set a price target for $4.00 expecting CXDO to rise to within 12 months (a possible 67.36% upside). 5 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Crexendo (CXDO)?

The latest analyst rating for Crexendo (NASDAQ: CXDO) was provided by Northland Capital Markets, and Crexendo initiated their outperform rating.

When is the next analyst rating going to be posted or updated for Crexendo (CXDO)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Crexendo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Crexendo was filed on September 27, 2022 so you should expect the next rating to be made available sometime around September 27, 2023.

Is the Analyst Rating Crexendo (CXDO) correct?

While ratings are subjective and will change, the latest Crexendo (CXDO) rating was a initiated with a price target of $0.00 to $4.00. The current price Crexendo (CXDO) is trading at is $2.39, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment